A combined dietary-physical activity intervention affects bone strength in obese children and adolescents

D Nemet1, E Berger-Shemesh, B Wolach

  • 1Child Health and Sports Center, Pediatric Department, Meir General Hospital, Sackler School of Medicine, Tel-Aviv University, Kfar-Saba, Israel.

Insights

A 3-month intervention combining diet and physical activity improved bone strength in obese children. This multidisciplinary approach is vital for treating pediatric obesity and its related bone health complications.

Area of Science:

  • Pediatric Endocrinology
  • Sports Medicine
  • Bone Physiology

Background:

  • Childhood obesity is a prevalent chronic disease.
  • Obese children may exhibit reduced bone strength compared to non-obese peers.
  • Interventions are needed to address obesity-related bone health issues in youth.

Purpose of the Study:

  • To prospectively evaluate the short-term effects of a 3-month combined dietary and physical activity intervention.
  • To assess changes in anthropometric measures, body composition, fitness, and bone strength in obese children.
  • To compare outcomes between an intervention group and a control group.

Main Methods:

  • A prospective study involving 12 obese children in an intervention group and 12 matched controls.
  • Intervention included a 3-month combined dietary and physical activity program.
  • Bone strength assessed via quantitative ultrasound measurements of bone speed of sound (SOS).

Main Results:

  • Significant improvements in the intervention group for body weight, BMI percentiles, body fat percentage, and endurance time.
  • A significant positive change in bone speed of sound (SOS) was observed in the intervention group compared to controls.
  • Intervention group showed a mean SOS change of 21.5 +/- 21.6 m/s, while controls showed -87.0 +/- 37 m/s (p=0.023).

Conclusions:

  • A combined dietary and physical activity intervention enhances bone strength in obese children.
  • These findings underscore the importance of multidisciplinary programs for managing childhood obesity.
  • Early intervention can mitigate complications like decreased bone strength during critical developmental periods.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Essential Minerals for Bone Health01:31

Essential Minerals for Bone Health

The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...